The March 20, 2009, article by Sandler et al, entitled, “Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab” (J Clin Oncol 27:1405–1412, 2009) contained errors.
In Table 4, under “Phase II + Phase III (early and late onset),” the data were inadvertently transposed between “presence of centrally located tumor” and “presence of centrally located node.”
The online version has been corrected in departure from the print.